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TECHNICAL NOTE
Partial right atrial inflow occlusion for controlled
systemic hypotension during thoracic endovascular
aortic repair
W. Anthony Lee, MD,a Tomas D. Martin, MD,b and Nikolaus Gravenstein, MD,c Gainesville, Fla
Controlled hypotension is sometimes necessary for accurate endograft deployment and adjunctive ballooning and
stenting near the arch and proximal descending thoracic aorta. This article describes a technique in which a compliant
occlusion balloon inflated in the right atrium is used to occlude the inflow from the inferior vena cava and reduce the
cardiac preload. This reliably and effectively induces systemic hypotension to any desired level and is also able to be rapidly
reversed. The technique has been used in 11 cases of thoracic endovascular aortic repairs with complete success and no
procedure-related complications. ( J Vasc Surg 2008;48:494-8.)Aortic impulse [P (mm Hg)  A (m2)  t (s)] is
directly proportional to the mean blood pressure (P), the
cross-sectional area of the aorta (A), and the duration of
systole (t), and generally varies inversely with the distance
from the aortic valve. High aortic impulses can cause sig-
nificant pulsatile motion of the arch and inadvertent move-
ment of endovascular devices during deployment. There-
fore, precise deployment of endografts and performance of
other adjunctive ballooning or stenting near the arch or the
proximal descending thoracic aorta may occasionally re-
quire induction of transient hypotension. We describe a
novel technique for rapid induction of systemic hypoten-
sion in a reproducible and reversible manner by reducing
the ventricular preload and cardiac output without the use
of any vasoactive pharmacologic agents.
TECHNIQUE
The common femoral vein is accessed using a standard
Seldinger technique. If open exposure is used to introduce the
endovascular delivery system, the adjacent femoral vein can be
easily exposed through the same incision.A small 5-0 polypro-
pylene pursestring stitch is placed in the femoral vein, and
transvenous access is obtained under direct vision. When the
ipsilateral vein is thrombosed or inaccessible, the contralateral
femoral vein may be percutaneously accessed. A guidewire is
advanced from the inferior vena cava (IVC) into the superior
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494vena cava (SVC) or one of the brachiocephalic veins, and a
12-F introducer sheath is inserted (Fig 1, A).
A compliant occlusion balloon (eg, Reliant Stent Graft
Balloon Catheter, Medtronic Inc, Minneapolis, Minn) is
introduced through the 12F venous sheath and advanced
to the right atrium, which is just cephalad to the medial
diaphragmatic shadow seen on an anteroposterior fluoro-
scopic projection (Fig 1, B) The balloon is manually in-
flated through a stopcock with a 30-mL syringe filled with
25% contrast-saline mixture to achieve a balloon diameter
of 25 to 30 mm (15 to 25 mL; Fig 2), and the stopcock is
closed. Correct atrial position may be confirmed with a
small injection of contrast (Fig 1,C) through the guidewire
port of the balloon catheter or simply by a globular appear-
ance of the balloon without any oblong deformity that
would be typically seen if it were inflated in the IVC.
The inflated balloon catheter is now retracted until the
operator feels a firm resistance at the atriocaval junction result-
ing in occlusion of IVC inflow to the right atrium.An assistant
applies constant traction to the balloon catheter during the
entire time that hypotension is desired. Excessive force should
be avoided to prevent inadvertent IVC avulsion from the right
atrium. The patient’s blood pressure is continuously moni-
tored through a peripheral arterial catheter. After initiation of
inflow occlusion, systemic blood pressure should begin to
decline rapidly and target hypotension (typically, systolic of 50
to 60 mm Hg) achieved in 60 to 90 seconds. If the blood
pressure decreases beyond what is desired, the retraction on
the balloon catheter is simply relaxed to allow transient return
of atrial inflow (Fig 3).
Any devices such as endografts, balloons, or stents that
are to be used should already be in position before atrial
inflow occlusion so that the intervention can be performed
immediately upon achieving target blood pressure and any
unnecessary period of hypotension avoided.
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tion on the atrial balloon is immediately relaxed and pushed
up slightly to lift it off the atriocaval junction while simul-
taneously being deflated. The blood pressure will immedi-
ately begin to rise, with restoration of normotension in 1 to
2 minutes.
At the conclusion of the thoracic endovascular proce-
dure, the balloon, guidewire, and sheath are removed, and
the previously placed pursestring is used to close the venot-
omy. In cases of percutaneous access, 15minutes of manual
compression after complete reversal of anticoagulation (ac-
tivated clotting time150 seconds) with protamine sulfate
Fig 1. Partial right atrial inflow occlusion technique.A,
artery and a 12F sheath (black arrow) is in the femoral
diaphragmatic border, and an aortic molding balloon is
C, An angiogram through the balloon catheter confirms
and distal endograft atrial inflow occlusion.is usually sufficient for hemostasis.CLINICAL EXPERIENCE
Between September 2007 and December 2007, the
technique of partial right atrial inflow occlusion was applied
in 11 patients undergoing thoracic endovascular aortic
repair (Table). The technique was used for adjunctive bal-
loon molding in nine patients (Fig 1,D and E) and Palmaz
stenting (Cordis Endovascular, Miami, Fla) at the proximal
and distal landing zones of the endograft in two patients.
There were no deaths or complications related to the
technique. All the femoral venous access sites were man-
aged either with direct suture repair of the vein (open)
dograft introducer sheath (white arrow) is in the femoral
B, The atrial balloon is positioned just cephalad to the
advanced through the previously deployed endograft.
ct atrial position.D, E, Balloon molding of the proximalAn en
vein.
being
correthrough the primary arterial access site or by manual com-
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hypotension was induced in 60 to 90 seconds from the time
the atrial balloon was inflated and retracted and was rapidly
reversed in 60 to 120 seconds (Fig 3).
DISCUSSION
During thoracic endovascular repair, short periods of
controlled hypotension are occasionally required to safely
and accurately deploy the endograft and perform other
types of adjunctive procedures such as balloonmolding and
stenting. These adjunctive procedures are obligatory with
certain devices such as the TAG, (W. L. Gore & Associates,
Flagstaff, Ariz) and discretionary with others.
Modulation of systemic pressures is typically achieved
pharmacologically using intravenous agents such as sodium
nitroprusside, nitroglycerine, or esmolol for hypotension,
and neosynephrine, dopamine, or epinephrine for hyper-
tension. All of these agents have in common a relatively rapid
onset of action and a short half-life of 2 to 5 minutes. How-
ever, the dose-response of these agents can be highly variable,
and in practice, the dose is titrated by either small boluses or
graded infusions until the desired effect is achieved.
Overshooting the target blood pressure either during
induction of hypotension or its reversal is common, result-
ing in a “roller-coaster” effect. This may be partially com-
pensated by slowing the rate of infusion of the vasoactive
agent, which has the disadvantage of prolonging the length
of time it takes to achieve hypotension, and conversely,
restoration of normotension upon completion of the inter-
vention. The duration of hypotension may also increase the
risk of complications such as stroke and spinal cord isch-
emia. Furthermore, these vasoactive agents may have dele-
terious secondary effects in the setting of ischemic heart
disease, reactive airway disease, and renal insufficiency.
Other methods of inducing hypotension have also been
used in practice. One method involves rapid ventricular
pacing using transvenous pacing wires.1 This technique is
Fig 2. Reliant Stent Graft Balloon Catheter compliance curve.
The balloon is constructed of a polyurethane material that has a
dynamic range of 10 to 46mm and a 100-cmworking length on an
8F catheter. The ex vivo balloon pressure remains at 0 mm Hg
through the working range of diameters.reliable and rapid, but it is disadvantaged by unfamiliarity ofmost operators with cardiac pacing, the risk of failure of return
to normal rhythm, and the increased oxygen demand of a
tachycardic myocardium during a period of relative decreased
coronary perfusion. It also involves devices that are not part of
the typical endovascular armamentarium.
The second method is the use of an adenosine bolus to
induce transient asystole.2,3 Although effective in most
instances, some patients only reach bradycardia instead of
asystole, the onset of action and dose-response are variable,
and duration of asystole is fairly short at a mean of 5
seconds, whichmay not allow sufficient time to perform the
intervention.
The technique of partial inflow occlusion has been
previously described by other authors as an effective means
to achieve controlled hypotension without the problems
Fig 3. Representative curves of systolic pressure (SBP, red line),
mean pressure (MAP, yellow line), and heart rate (HR, blue line)
from two patients who required molding balloons after endograft
deployment. Pressures were measured from the right radial arterial
catheter. A, Atrial inflow occlusion initiated, 1; target hypotension
reached, 2; proximal aortic molding balloon inflated, 3; and atrial
balloon relaxed and deflated, 4.B,Atrial inflow occlusion initiated,
1; target hypotension reached, 2; proximal aortic molding balloon
inflated, 3; aortic balloon deflated, 4; aortic balloon re-inflated,
5; atrial balloon relaxed, 6; distal aortic balloon inflated, 7; distal
aortic balloon deflated, 8; distal aortic balloon re-inflated, 9; and
distal aortic balloon and atrial balloon deflated, 10. BPM,
beats/min.encountered with conventional pharmacologic methods.4,5
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on any biochemical adjuncts, our technique is able to
induce and reverse systemic hypotension to any desired
level in a rapid and safe manner.
Approximately 20% of the cardiac output is used to
perfuse the coronary arteries and the great vessels supplying
the brain (15%) and the upper extremities.6 Of the remain-
ing 80% of the aortic blood flow, 65% to 70% of its venous
return enters the right atrium from the IVC, with the
balance made up from the azygous veins and the coronary
sinus. Therefore, by occluding the IVC at the atriocaval
junction, most of the preload is acutely reduced, with
concomitant lowering of the cardiac output and systemic
blood pressure. This phenomenon has been historically
observed during management of retrohepatic caval injury
requiring IVC occlusion and orthotopic liver transplantation,
where severe hypotension can occur immediately after cross-
clamping the IVC unless the patient is supported with an
atriocaval shunt during the anhepatic phase of the procedure.
The compliance characteristics of the Reliant balloon
are given in Fig 2. In one magnetic resonance imaging
study, the mean diameter of the human infrarenal IVC was
23.5  4 mm.7 The mean diameter of the suprahepatic
IVC (Table) in our 11 patients was slightly larger at 28.1
3 mm. Therefore, a 25-mL inflation of the Reliant balloon
(34.4-mm diameter) should achieve sufficient diameter to
occlude the IVC in 95% of patients.
We have also considered modification of our technique
to bicaval inflow occlusion by introduction of a second
balloon catheter through the internal jugular vein that
would be used to occlude the inflow from the SVC, as was
originally described by Ishiguchi et al.8 But given how
effective IVC inflow occlusion alone was in reducing the
Table. Eleven consecutive thoracic endovascular aortic proc
No. Age Sex Indication Device
Prox d
(mm
1 52 M Type B dissection TAGe 40
2 66 F TAA (s/p elephant trunk TAG 31
3 78 F TAA TAG 37
4 71 M TAA Relayg 36
5 81 F TAA (s/p elephant trunk TAG 31
6 74 M TAA TAG 37
7 85 M TAA Valianth 44
8 88 F TAA Relay 36
9 81 F TAA (s/p elephant trunk TAG 31
10 42 M Transection TAG 26
11 35 M Type B dissection TAG 26
IVC, Inferior vena cava; SH, suprahepatic; TAA, thoracic aortic aneurysm.
aProximal and distal diameters of the endografts deployed at the proximal a
bMethod of femoral venous access for the 12F sheath.
cDiameter of the suprahepatic inferior vena cava immediately caudal to the
axis)/2].
dInterventional procedure performed during inflow occlusion.
eW. L. Gore, Flagstaff, Ariz.
fCordis, Johnson & Johnson, Miami, Fla.
gRelay, Bolton Medical, Sunrise, Fla.
hValiant, Medtronic, Santa Rosa, Calif.blood pressure and the theoretic benefit of preservingmyocardial and cerebral perfusion by maintaining some
(about 20%) level of cardiac output to the coronary and
carotid arteries during periods of ballooning, stenting, or
any intervention that involves distal aortic arch occlusion,
we did not believe the additional technical complexity of a
second balloon catheter was justified.
Deep venous thrombosis at the percutaneous insertion
site is a recognized complication after femoral vein access
for IVC filter placement. Although largely clinically asymp-
tomatic, they have been identified in 25% to 40% of patients
on duplex imaging.9,10 Duplex imaging was not routinely
performed; however, standard triple-phase postoperative
computed tomography angiography was performed either
before discharge or at 1 month in all patients. Examination
of the common femoral veins at the sites of insertion did
not show any evidence of acute deep venous thrombosis.
CONCLUSION
Partial right atrial inflow occlusion is a technique that
allows for the rapid and controlled reduction of systemic
blood pressure using simple interventional equipment that
is readily available in any practice that performs endovascu-
lar aortic therapy. We believe that this may be a useful
adjunct during endovascular interventions involving the
thoracic aorta. The safety of this technique, however,
should be demonstrated in a larger study before its wide-
spread adoption.
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